Quality Measures Nominated for 2023

The ACR participated in the annual CMS Qualified Clinical Data Registry (QCDR) self-nomination process for the Merit-based Incentive Payment System (MIPS) performance year 2023. The ACR submitted the following quality measures for CMS consideration within the 2023 QCDR nomination package:

• ACRad 15: Report Turnaround Time: Radiography.
• ACRad 16: Report Turnaround Time: Ultrasound (Excluding Breast US).
• ACRad 17: Report Turnaround Time: MRI.
• ACRad 18: Report Turnaround Time: CT.
• ACRad 19: Report Turnaround Time: PET.
• ACRad 25: Report Turnaround Time: Mammography.
• ACRad 34: Multi-Strata Weighted Average for Three CT Exam Types (Overall percent of CT exams for which dose length product is at or below the size-specific diagnostic reference level for CT abdomen-pelvis with contrast/single phase scan, CT chest without contrast/single phase scan and CT head/brain).
• ACRad 36: Incidental Coronary Artery Calcification Reported on Chest CT.
• ACRad 37: Interpretation of CT Pulmonary Angiography for Pulmonary Embolism.
• ACRad 38: Use of Low Dose Cranial CT or MRI Examinations for Patients with Ventricular Shunts.
• ACRad 40: Use of Structured Reporting in Prostate MRI.
• ACRad 41: Use of Quantitative Criteria for Oncologic FDG PET Imaging.
• ACRad 42: Surveillance Imaging for Liver Nodules <10mm in Patients at Risk for Hepatocellular Carcinoma.

Additionally, ACR included nine measures licensed from the MSN Healthcare Solutions QCDR in our self-nomination. If approved, this suite of QCDR measures will become available for use by MIPS-eligible radiologists using the ACR National Radiology Data Registry MIPS Participation Portal for meeting the MIPS quality measurement requirement. Over the coming months, CMS will release the results of the ACR self-nomination in time for using the measures during the 2023 MIPS performance year.

Please visit the ACR QCDR webpage for more information about MIPS reporting.